Inventor · disambiguated record
Alexander J. Pickrell
Also filed as: PICKRELL ALEXANDER · PICKRELL ALEXANDER J
28 granted patents·12 pending applications·196 citations·filing 2007–2025
96Inventor score
Top patents by PatentIndex Score
40 records- 0198US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0298US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0398US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 0497US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 0596US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0696US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 0793US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 0893US10632128B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Apr 28, 2020·5 cites·49 claims
- 0990US9718803B2Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2015·Granted Aug 1, 2017·8 cites·19 claims
- 1090US8957073B2Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Feb 17, 2015·15 cites·31 claims
- 1188US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1287US7635715B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Dec 22, 2009·7 cites·50 claims
- 1385US2025362134A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1482US9303028B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2014·Granted Apr 5, 2016·4 cites·18 claims
- 1582US2025057817A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 1680US8691986B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Apr 8, 2014·3 cites·8 claims
- 1780US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 1879US8946230B2Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Feb 3, 2015·5 cites·24 claims
- 1979US8318718B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Nov 27, 2012·4 cites·94 claims
- 2078US9174992B2Heterobicyclic compoundsAMGEN INC·Filed 2013·Granted Nov 3, 2015·4 cites·17 claims
- 2177US8637500B2Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Jan 28, 2014·3 cites·18 claims
- 2274US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 2374US2022168280A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2022·Application pending·0 cites
- 2472US11224601B1Compounds that inhibits MCL-1 proteinAMGEN INC·Filed 2020·Granted Jan 18, 2022·0 cites·15 claims
- 2569US10821115B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2020·Granted Nov 3, 2020·0 cites·43 claims
- 2669US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 2765US2024409557A15,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulatorsAMGEN INC·Filed 2024·Application pending·0 cites
- 2861US7928139B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2009·Granted Apr 19, 2011·0 cites·30 claims
- 2959US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 3057US9493459B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2016·Granted Nov 15, 2016·0 cites·3 claims
- 3157US2014213572A1Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 3256US2023406860A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 3355US2024059703A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 3454US2016280703A1Heteroaryloxycarbocyclyl Compounds as PDE 10 InhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 3552US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 3649US8759532B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2012·Granted Jun 24, 2014·0 cites·80 claims
- 3748US10889581B2Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 12, 2021·0 cites·21 claims
- 3848US8952037B2Heteroaryloxycarbocyclyl compounds as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Feb 10, 2015·0 cites·13 claims
- 3946US9328134B2Carbohydrate phosphonate derivatives as modulators of glycosylationAMGEN INC·Filed 2014·Granted May 3, 2016·0 cites·38 claims
- 4046US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →